StonvexLoading…
StonvexStonvexStonvexCore line items from NRDY's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $48.73M | $178.99M | $129.88M | $92.86M |
Operating Income | $-5.80M | $-61.86M | $-47.95M | $-28.87M |
Net Income | $-4.08M | $-39.92M | $-30.68M | $-18.39M |
EPS (Diluted) | $-0.03 | $-0.33 | $-0.26 | $-0.15 |
Total Assets | $72.97M | $76.17M | $70.41M | $73.69M |
Total Liabilities | $44.04M | $47.23M | $33.35M | $24.95M |
Cash & Equivalents | $44.70M | $47.90M | $32.71M | $36.72M |
Free Cash Flow OCF − CapEx | $-2.96M | $-24.22M | $-19.96M | $-15.82M |
Shares Outstanding | 124.30M | 120.83M | 120.09M | 119.30M |